Alessandro Pezzini Selected Research

Blood Vessel Dissection

1/2022	Antithrombotic therapy in the postacute phase of cervical artery dissection: the Italian Project on Stroke in Young Adults Cervical Artery Dissection.
1/2022	Spontaneous cervical artery dissection and fibromuscular dysplasia: Epidemiologic and biologic evidence of a mutual relationship.
12/2011	Mutations in TGFBR2 gene cause spontaneous cervical artery dissection.
12/2007	Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect.
9/2007	Antiplatelets versus anticoagulation in cervical artery dissection.
3/2006	Diagnostic flow chart for targeted detection of alpha1-antitrypsin deficiency.
10/2002	Hyperhomocysteinemia: a potential risk factor for cervical artery dissection following chiropractic manipulation of the cervical spine.
3/2002	Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke.
1/2002	Alpha-1-antitrypsin deficiency-associated cervical artery dissection: report of three cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Pezzini Research Topics

Disease

36	Stroke (Strokes) 01/2022 - 03/2002
26	Ischemic Stroke 01/2022 - 03/2002
11	Atrial Fibrillation 01/2022 - 01/2012
9	Hemorrhage 01/2022 - 08/2015
9	Blood Vessel Dissection 01/2022 - 01/2002
7	COVID-19 07/2022 - 01/2020
7	Cerebral Hemorrhage 01/2021 - 06/2013
5	Hypertension (High Blood Pressure) 10/2021 - 02/2004
5	Brain Ischemia (Cerebral Ischemia) 09/2021 - 01/2007
5	Migraine Disorders (Migraine) 01/2021 - 04/2006
4	Myocardial Infarction 03/2015 - 01/2004
3	Leukocytosis (Pleocytosis) 10/2022 - 01/2020
3	Fibromuscular Dysplasia 01/2022 - 01/2014
3	Infections 10/2021 - 01/2014
3	Hematoma 01/2020 - 02/2014
2	Pulmonary Embolism 01/2020 - 09/2012
2	Infarction (Infarctions) 05/2019 - 03/2012
2	Leukoaraiosis 01/2019 - 03/2017
2	Migraine with Aura (Familial Hemiplegic Migraine) 01/2019 - 04/2014
2	Embolic Stroke 01/2019 - 08/2015
2	Embolism (Embolus) 06/2017 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 08/2004
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2008 - 01/2007
2	Hyperhomocysteinemia 01/2007 - 10/2002
1	Fever (Fevers) 05/2021
1	Neurologic Manifestations (Neurological Manifestations) 11/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Hypercholesterolemia 01/2020
1	Venous Thromboembolism 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Wounds and Injuries (Trauma) 06/2019
1	Disease Progression 03/2019
1	Disease Susceptibility (Diathesis) 03/2019
1	Epilepsy (Aura) 01/2019
1	Pain (Aches) 01/2019
1	Thrombosis (Thrombus) 06/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2016
1	Patent Foramen Ovale 01/2016
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 05/2014
1	Neck Pain (Cervicalgia) 01/2014
1	Obesity 06/2013

Drug/Important Bio-Agent (IBA)

17	AnticoagulantsIBA 01/2022 - 09/2007
5	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2011
5	Biological ProductsIBA 01/2022 - 01/2011
5	Vitamin K FDA Link 01/2021 - 09/2015
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 06/2009
5	HomocysteineIBA 01/2008 - 03/2002
4	ORALIT (ORS)IBA 10/2021 - 02/2004
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 01/2016
3	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2021 - 01/2012
3	Apolipoproteins E (ApoE)IBA 01/2019 - 02/2004
3	ApolipoproteinsIBA 01/2019 - 02/2004
3	CholesterolIBA 01/2016 - 06/2009
3	Prothrombin (Factor II)IBA 03/2015 - 03/2005
3	Folic Acid (Vitamin M)FDA LinkGeneric 02/2011 - 01/2004
2	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2017
2	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 04/2014
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019 - 09/2012
2	Factor V (Coagulation Factor V)IBA 03/2015 - 03/2005
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 02/2011 - 01/2007
2	Fibrinogen (Factor I)FDA Link 01/2008 - 08/2004
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2007 - 03/2005
2	Vitamin E FDA LinkGeneric 08/2004 - 01/2004
1	C-Reactive ProteinIBA 10/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022
1	Oxygen (Dioxygen)IBA 05/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	SteroidsIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	parthenolideIBA 01/2019
1	MagnesiumIBA 01/2019
1	TabletsIBA 01/2019
1	Tryptophan (L-Tryptophan)FDA Link 01/2019
1	Endothelial Protein C ReceptorIBA 01/2018
1	Protein CIBA 01/2018
1	ThrombomodulinIBA 01/2018
1	Warfarin (Coumadin)FDA LinkGeneric 01/2018
1	activated protein C receptorIBA 01/2018
1	RivaroxabanIBA 11/2017
1	Dabigatran FDA Link 11/2017
1	apixabanIBA 11/2017
1	HDL CholesterolIBA 11/2016
1	Serine Proteases (Serine Protease)IBA 02/2016
1	Clopidogrel (Plavix)FDA Link 01/2016
1	TNF Receptor-Associated Factor 3IBA 01/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016
1	N(4)-oleylcytosine arabinosideIBA 09/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2015
1	Antiphospholipid AntibodiesIBA 04/2014
1	Dihydrotachysterol (AT 10)IBA 04/2014

Therapy/Procedure

20	Therapeutics 01/2022 - 01/2007
7	Secondary Prevention 01/2022 - 05/2009
6	Thrombectomy 10/2021 - 03/2017
2	Thrombolytic Therapy 01/2020 - 01/2012
1	Musculoskeletal Manipulations (Manipulative Therapy) 06/2019
1	Spinal Manipulation 01/2014